FDA Extends Comment Period for Draft Guidance on Export and Import Regulations

Summary

The Food and Drug Administration (FDA) has extended the comment period for its draft guidance on export and import regulations under the FDA Export Reform and Enhancement Act of 1996 until November 24, 1998, in response to a request from the Health Industry Manufacturers Association.